Anna Protopapas

2023

In 2023, Anna Protopapas earned a total compensation of $4.5M as Former President and Chief Executive Officer at Mersana Therapeutics, a 56% increase compared to previous year.

Compensation breakdown

Option Awards$3,019,207
Salary$448,333
Stock Awards$757,500
Other$224,969
Total$4,450,009

Protopapas received $3M in option awards, accounting for 68% of the total pay in 2023.

Protopapas also received $448.3K in salary, $757.5K in stock awards and $225K in other compensation.

Rankings

In 2023, Anna Protopapas' compensation ranked 159th out of 2,978 executives tracked by ExecPay. In other words, Protopapas earned more than 94.7% of executives.

ClassificationRankingPercentile
All
159
out of 2,978
95th
Division
Manufacturing
84
out of 1,637
95th
Major group
Chemicals And Allied Products
51
out of 906
94th
Industry group
Drugs
50
out of 869
94th
Industry
Pharmaceutical Preparations
33
out of 627
95th
Source: SEC filing on April 26, 2024.

Protopapas' colleagues

We found six more compensation records of executives who worked with Anna Protopapas at Mersana Therapeutics in 2023.

2023

Martin Huber

Mersana Therapeutics

Chief Executive Officer

2023

Arvin Yang

Mersana Therapeutics

Chief Medical Officer

2023

Brian DeSchuytner

Mersana Therapeutics

Chief Financial Officer

2023

Timothy Lowinger

Mersana Therapeutics

Senior Vice President, Chief Science and Technology Officer

2023

Alejandra Carvajal

Mersana Therapeutics

Chief Legal Officer

2023

Mohan Bala

Mersana Therapeutics

Senior Vice President, Chief Development Officer

News

In-depth

You may also like